Multi-dimensional imaging in early AMD

Dr Richard Unwin, Manchester University -£23,931
Early age-related macular degeneration (AMD) is closely linked to the switching on and off of the part of the immune system called the complement system. This system is genetically influenced and plays a key role in inflammation and defending against bacterial infections.
What is the problem?
The complement system consists of over 40 individual components. Currently, these components can only be studied separately in eye tissue, limiting our understanding of how they interact and contribute to AMD development.
What are they doing?
By use of a new technology called ‘imaging mass cytometry’ this project will develop a means of looking at several components together. The process involves binding a specific metal to an antibody. The antibody then bonds to its target, one of the molecules of the complement system. The exact positioning of the target molecule can be detected using a laser.
How will this help?
This new imaging method will give a greater understanding of molecular changes in the retina as AMD develops.
See our other projects
Since 1987 the Macular Society has invested around £10 million in over 100 research projects.
Explore more research
Beating macular disease through funding medical research and improving the lives of those living with macular disease.

Get the latest research news from the Macular Society
To hear about life-changing research and treatments, subscribe to our monthly enewsletter today. Together we can Beat Macular Disease.
Sign up to our free email newsletter